Always a lot to take in quickly and I look forward to more measured analysis over the day. Key for me was Novartis decision in next few weeks. However they were very positive. We now know where the company focus is certainly for next quarter. I don’t think they have given up on over 65’s. It’s a therapy that allows the body to heal. The older are less resilient and comorbidities must play a factor. As SI said I believe, if we can dose more and earlier we may still make a difference.
We appear to have enough cash for 6 quarters which means 12 months before that clock starts ticking.
All fine and dandy, imo the recent fall was over done but in essence the wait continues.
Big unanswered question, given SI previous form on timing is........
How long is a few weeks, SI time? Move over the $64,000 US dollar question. This one is perhaps the $5 Billion dollar question, so I hope the answer is 2.
Nearly 1.00am time for a kip. Enjoy the speculation and I hope to wake up in 4 hours with my Australian fellow investors a nice shade of green.
regards
Yelrom.
Ann: COVID ARDS Trial Topline 60-Day Results, page-62
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.51 |
Change
0.155(11.5%) |
Mkt cap ! $1.644B | |||
| Open | High | Low | Value | Volume |
| $1.37 | $1.53 | $1.37 | $17.29M | 11.97M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 61523 | $1.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.51 | 44388 | 13 |
View Market Depth
| Last trade - 13.25pm 04/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |